EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Normalized Creatinine-to-Cystatin C Ratio and Risk of Cardiometabolic Multimorbidity in Middle-Aged and Older Adults: Insights from the China Health and Retirement Longitudinal Study

Honglin Sun, Zhenyu Wu, Guang Wang, Jia Liu

Diabetes & Metabolism Journal · 01.05.2025 · 49 (3) · 448-461

DOI: 10.4093/dmj.2024.0100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 01.05.2025. Verfasst von Honglin Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Cystatin C, Creatinine, Cardiovascular Diseases, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Capital Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Normalized creatinine-to-cystatin C ratio (NCCR) was reported to approximate relative skeletal muscle mass and diabetes risk. However, the association between NCCR and cardiometabolic multimorbidity (CMM) remains elusive. This study aimed to explore their relationship in a large-scale prospective cohort.

Methods

This study included 5,849 middle-age and older participants from the China Health and Retirement Longitudinal Study (CHARLS) enrolled between 2011 and 2012. The baseline NCCR was determined as creatinine (mg/dL)/cystatin C (mg/L)×10/body mass (kg). CMM was defined as the simultaneous occurrence of two or more of the following conditions: heart disease, stroke, and type 2 diabetes mellitus. Logistic regression analysis and Cox regression analysis were employed to estimate the relationship between NCCR and CMM. The joint effect of body mass index and NCCR on the risk of CMM were further analyzed.

Results

During a median 4-year follow-up, 227 (3.9%) participants developed CMM. The risk of CMM was significantly decreased with per standard deviation increase of NCCR (odds ratio, 0.72; 95% confidence interval, 0.62 to 0.85) after adjustment for confounders (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystatin CCreatinineCardiovascular DiseasesDiabetes Mellitus, Type 2Heart DiseasesHumansFemaleMaleAgedLongitudinal StudiesMiddle AgedChinaMultimorbidityProspective StudiesRisk FactorsBody Mass IndexBiomarkers

Stichwörter der Autor:innen

CreatinineCystatin CMultimorbidityObesityProspective studies

Substanzen

Cystatin CCreatinineBiomarkers

Autor:innen und Institutionen

  • Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Capital Medical University
  • Beijing Natural Science Foundation

Zitieren

APA

Sun, H., Wu, Z., Wang, G., & Liu, J. (2025). Normalized Creatinine-to-Cystatin C Ratio and Risk of Cardiometabolic Multimorbidity in Middle-Aged and Older Adults: Insights from the China Health and Retirement Longitudinal Study. Diabetes & Metabolism Journal, 49(3), 448-461. https://doi.org/10.4093/dmj.2024.0100

Vancouver

Sun H, Wu Z, Wang G, Liu J. Normalized Creatinine-to-Cystatin C Ratio and Risk of Cardiometabolic Multimorbidity in Middle-Aged and Older Adults: Insights from the China Health and Retirement Longitudinal Study. Diabetes & Metabolism Journal. 2025;49(3):448-461. doi:10.4093/dmj.2024.0100

BibTeX
@article{Sun2025,
  author = {Sun, Honglin and Wu, Zhenyu and Wang, Guang and Liu, Jia},
  title = {Normalized Creatinine-to-Cystatin C Ratio and Risk of Cardiometabolic Multimorbidity in Middle-Aged and Older Adults: Insights from the China Health and Retirement Longitudinal Study},
  journal = {Diabetes & Metabolism Journal},
  year = {2025},
  volume = {49},
  number = {3},
  pages = {448--461},
  doi = {10.4093/dmj.2024.0100}
}
Kostenlos starten →